Enhancing acute myeloid leukemia therapy - monitoring response using residual disease testing as a guide to therapeutic decision-making.
about
Enhancing acute myeloid leukemia therapy - monitoring response using residual disease testing as a guide to therapeutic decision-making.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Enhancing acute myeloid leukem ...... o therapeutic decision-making.
@en
Enhancing acute myeloid leukem ...... o therapeutic decision-making.
@nl
type
label
Enhancing acute myeloid leukem ...... o therapeutic decision-making.
@en
Enhancing acute myeloid leukem ...... o therapeutic decision-making.
@nl
prefLabel
Enhancing acute myeloid leukem ...... o therapeutic decision-making.
@en
Enhancing acute myeloid leukem ...... o therapeutic decision-making.
@nl
P2860
P1476
Enhancing acute myeloid leukem ...... o therapeutic decision-making.
@en
P2093
Benjamin Tomlinson
P2860
P304
P356
10.1080/17474086.2017.1326811
P577
2017-05-05T00:00:00Z